Integrating Circulating Tumor DNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy

Scientists developed a therapeutic approach integrating circulating tumor DNA dynamics with sequential organoid drug screening to optimize breast cancer treatment. Analysis of 40 breast cancer organoid models demonstrated the potential of organoid culture supernatants for comprehensive mutation profiling and drug sensitivity testing.